CD101: a novel long‐acting echinocandin

CD101 is a novel echinocandin drug being developed to treat severe fungal infections including invasive candidiasis. We have performed a series of studies to evaluate the antifungal properties of CD101 against both echinocandin‐susceptible and ‐resistant Candida strains. Antifungal susceptibility te...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yanan, Perez, Winder B., Jiménez‐Ortigosa, Cristina, Hough, Grayson, Locke, Jeffrey B., Ong, Voon, Bartizal, Ken, Perlin, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Special Issue ‐ Original articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096055/
https://www.ncbi.nlm.nih.gov/pubmed/27354115
http://dx.doi.org/10.1111/cmi.12640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096055/
https://www.ncbi.nlm.nih.gov/pubmed/27354115
http://dx.doi.org/10.1111/cmi.12640

Ejemplares similares